ArticleBMC cancer2026

Pharmacokinetics, safety, and efficacy of fuzuloparib in combination with abiraterone acetate and prednisone in patients with metastatic castration-resistant prostate cancer: a phase 1 dose escalation and expansion study.

Tao Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.